Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

DOACs after TAVR may put some patients at risk, new meta-analysis suggests

The new study, based on data from nearly 3,000 patients, compared DOACs such as rivaroxaban, apixaban and edoxaban with single and dual antiplatelet therapy. 

soft tissue lymphoma versus soft tissue tumor

Soft tissue lymphomas versus soft tissue tumors: MRI features reliably differentiate between the two

A new analysis offers a detailed comparison of soft-tissue lymphomas and soft-tissue tumors based on imaging characteristics from MRI scans—an area of study that has not yet been rigorously explored, the authors of the paper indicated.

artificial sweetener sweet sugar aspartame diet healthy CVD heart attack stroke

Aspartame, other artificial sweeteners linked to significant heart problems

These findings, researchers wrote, suggest that artificial sweeteners "should not be considered a healthy and safe alternative to sugar."

Photon-counting CT/AI combo improves multiple myeloma detection

When combined with artificial intelligence-based noise reduction techniques, new photon-counting CT technology can increase the detection of bone disease while also decreasing radiation exposure. 

Watchman FLX left atrial appendage closure (LAAC)

Boston Scientific gains a new FDA approval for Watchman FLX LAAC device

The company can now update its labeling instructions for the device to include a new 45-day dual anti-platelet therapy treatment option when treating non-valvular atrial fibrillation. 

How AI could be the key to beating the next COVID-19 variant

While the number of possible mutations of the SARS-CoV-2 spike protein would be overwhelming for humans to analyze, machine learning may be able to offer critical insights for next-generation vaccines and antibody treatments. 

SAVR after TAVR is rare, but linked to a high mortality risk

Researchers tracked data from more than 2,000 patients, noting that surgical bailout, infective endocarditis and paravalvular leak were the most common reasons for surgery to be required after TAVR. The full study was published in the American Journal of Cardiology.

heart patient

TEER safe and feasible for patients with atrial secondary mitral regurgitation

Atrial secondary mitral regurgitation has been linked to higher in-hospital mortality and hospitalization rates.